Oui Therapeutics
PrivateLast Round
Grant
Jun 5, 2024
Total Funding Raised
$34.56M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oui Therapeutics operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Grant round in June 2024.
Oui Therapeutics is a digital health company that develops prescription digital therapeutics and mobile-based platforms designed to provide life-saving behavioral interventions for patients at risk of suicide.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oui Therapeutics Comparables
Compare Oui Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jaspr Health | 80% | |
| PursueCare | 77% | |
| Big Health | 76% |
For institutional investors. Book with your work email.
Oui Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 5, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Series A | Aug 2, 2022 | ||||
| Grant | Aug 1, 2021 | ||||
| Grant | Jul 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oui Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| Aetna Ventures | Series A |
| Flare Capital Partners | Series A |
| First Round Capital | Series A |
| CVS Health Ventures | Series A |
| Athyrium Capital Management | Series A |
| Polaris Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 138% MoM, reaching 1.4K.
- Jul 28, 2026
Monthly visitors grew 61% MoM.
For institutional investors. Book with your work email.
Oui Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oui Therapeutics's valuation, stock price, and market status.
Is Oui Therapeutics a public or private company?
Oui Therapeutics is a private company.
What is the current stock price of Oui Therapeutics?
Oui Therapeutics is a private company, so its shares have no public market price. Caplight tracks Oui Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oui Therapeutics worth (valuation)?
Valuation information for Oui Therapeutics is not publicly available.
Can I buy Oui Therapeutics stock?
Oui Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oui Therapeutics's last funding round?
Oui Therapeutics's most recent funding round was Grant on June 5, 2024.
Who are the main investors in Oui Therapeutics?
Key investors in Oui Therapeutics include National Institute of Mental Health, Aetna Ventures, CVS Health Ventures, Athyrium Capital Management.
Will Oui Therapeutics IPO soon?
No public IPO plans have been announced for Oui Therapeutics.
How can I track Oui Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Oui Therapeutics's shares on secondary markets.